Zsofia Torocsik Sets New DYN Women’s World Record - DeeperBlue.com
4 days ago • Google News
Dyne Therapeutics Inc (DYN)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 1.76B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
0
52W High
$ 47.45
52W Low
$ 6.36
Dividend Yield
0.00%
Beta
1.08
Technicals
50-Day MA
10.6312
200-Day MA
15.6261
52 Week High
47.45
52 Week Low
6.36
About DYN
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.
Employees
206
Headquarters
Waltham, MA
CEO
Mr. John G. Cox M.B.A.